Dr. Nagendran on Family History, BRCA Status, and Risk

Sukumar Nagendran, MD
Published Online: Monday, January 20, 2014
Sukumar Nagendran, MD, vice president, medical affairs, Quest Diagnostics, discusses a study looking at patients’ family history, BRCA mutation status, and breast cancer risk.

This study found that patients who have tested negative for BRCA2 but have a strong family history of breast cancer still have an increased risk of breast cancer.

Nagendran wonders if there are other single-nucleotide polymorphisms (SNPs) within family members that have not been identified, if the patients in this study were affected by an environmental factor, and if these patients should have additional screening (such as MRI) of their breast.

Nagendran says further research is needed in this area.
Online CME Activities
Free CME from PER
Evolving Management Strategies for Triple-Negative Breast Cancer
Community Practice Connections™: Current and Emerging Strategies in the Management of Early Breast Cancer
Cancer Summaries and Commentaries™: Update from Vienna: Advances in the Treatment of Gastrointestinal Cancers
Advances in Targeted Therapy: The Emerging Role of PARP Inhibitors in the Treatment of Cancers
More Reading